OS Therapies Incorporated (OSTX) financial statements and ratios from SEC XBRL: revenue $249.00 (TTM), net margin -11547728.5%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $249.00 |
| Net Margin | -11547728.5% |
| Return on Equity | 330.4% |
| Debt / Equity | -0.01 |
| Current Ratio | 0.18 |
| Price / Sales | 344222.57 |
| FCF Yield | -15.9% |
| Altman Z-Score | -26.86 (distress) |
| Sector P/E (Healthcare) | 21.7 |
OSTX overview · OSTX earnings · OSTX KPIs · OSTX investor relations · OSTX ownership · OSTX peers · OSTX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.